Year: 2020
Type: article
Abstract: Insulin gene mutations have been identified to cause monogenic diabetes, and most of which developed permanent neonatal diabetes at young ages before 6 months of age in humans. To establish an animal model of permanent diabetes, we performed genome editing using the CRISPR/Cas9 system. We generated a novel Kuma mutant mice with p.Q104del in the Insulin2 (Ins2) gene in a BRJ background that exhibits a severe immune deficiency. Kuma mutant mice are non-obese and developed hyperglycemia from 3 weeks after birth in both males and females, which are inherited in a dominant mode. Kuma mutant mice displayed reduced insulin protein levels from 3-weeks-old, which seem to be caused by the low stability of the mutant insulin protein. Kuma mutant showed a reduction in islet size and islet mass. Electron microscopic analysis revealed a marked decrease in the number and size of insulin granules in the beta-cells of the mutant mice. Hyperglycemia of the mutant can be rescued by insulin administration. Our results present a novel insulin mutation that causes permanent early-onset diabetes, which provides a model useful for islet transplantation studies.
Source: Scientific Reports
Language: English
Subfield: Endocrinology, Diabetes and Metabolism
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $1,870
Awards: 疾患モデル高度化による視床下部・下垂体難病研究, Advanced Bioimaging Support, Elucidation of monoamine-GPCR signal-regulated pancreatic beta cell differentiation and maturation mechanism, Correlative light and electron microscopy (CLEM) to identify propagating synuclein aggregates in the brain, Elucidation of the functional regulatory mechanism of pancreatic islets via monoamine signaling, 多能性幹細胞を用いた膵β細胞の成熟化機構解明, The mechanism for the maintenance of pancreatic beta cells derived by in vitro differentiation of human pluripotent stem cells
OpenAlex ID: W3045178656
